JunB breakdown in mid-/late G2 is required for down-regulation of cyclin A2 levels and proper mitosis

Farras, R.; Baldin, V.; Gallach, S.; Acquaviva, C.; Bossis, G.; Jariel-Encontre, I.; Piechaczyk, M.

Mol Cell Biol

2008-06 / vol 28 / pages 4173-87


JunB, a member of the AP-1 family of dimeric transcription factors, is best known as a cell proliferation inhibitor, a senescence inducer, and a tumor suppressor, although it also has been attributed a cell division-promoting activity. Its effects on the cell cycle have been studied mostly in G1 and S phases, whereas its role in G2 and M phases still is elusive. Using cell synchronization experiments, we show that JunB levels, which are high in S phase, drop during mid- to late G2 phase due to accelerated phosphorylation-dependent degradation by the proteasome. The forced expression of an ectopic JunB protein in late G2 phase indicates that JunB decay is necessary for the subsequent reduction of cyclin A2 levels in prometaphase, the latter event being essential for proper mitosis. Consistently, abnormal JunB expression in late G2 phase entails a variety of mitotic defects. As these aberrations may cause genetic instability, our findings contrast with the acknowledged tumor suppressor activity of JunB and reveal a mechanism by which the deregulation of JunB might contribute to tumorigenesis.

Read on PubMed


Humans; *Gene Expression Regulation; Models, Biological; Phosphorylation; Transcription Factor AP-1/*metabolism; Microscopy, Fluorescence; Genetic Vectors; *Mitosis; Cell Cycle; Hela Cells; Proteasome Endopeptidase Complex/metabolism; *Down-Regulation; G2 Phase; Cyclin A/*metabolism; Proto-Oncogene Proteins c-jun/metabolism

Back to all publications